Charles Schwab Investment Management Inc. Buys 17,159 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Charles Schwab Investment Management Inc. increased its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 16.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,278 shares of the company’s stock after purchasing an additional 17,159 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in ASP Isotopes were worth $334,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in shares of ASP Isotopes during the third quarter worth $6,249,000. Marshall Wace LLP boosted its holdings in shares of ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after acquiring an additional 433,734 shares in the last quarter. GSA Capital Partners LLP boosted its holdings in shares of ASP Isotopes by 96.0% during the 3rd quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after acquiring an additional 377,721 shares in the last quarter. Fiera Capital Corp bought a new stake in ASP Isotopes during the 3rd quarter worth $723,000. Finally, Bank of New York Mellon Corp acquired a new position in ASP Isotopes in the 2nd quarter worth about $381,000. Institutional investors own 16.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ASPI. Canaccord Genuity Group started coverage on ASP Isotopes in a research note on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock. Canaccord Genuity Group reiterated a “buy” rating and set a $4.50 target price on shares of ASP Isotopes in a research report on Friday, October 18th.

ASP Isotopes Stock Performance

Shares of ASP Isotopes stock opened at $4.35 on Friday. The stock has a market cap of $310.55 million, a price-to-earnings ratio of -7.13 and a beta of 3.27. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. ASP Isotopes Inc. has a twelve month low of $1.65 and a twelve month high of $9.33. The company’s fifty day moving average is $5.79 and its 200 day moving average is $3.91.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.